Sacchi de Camargo Correia, Guilherme
Pai, Tanmayi
Li, Shenduo
Connor, Dana
Zhao, Yujie
Lou, Yanyan
Manochakian, Rami https://orcid.org/0000-0001-9142-4113
Article History
Accepted: 30 August 2023
First Online: 2 October 2023
Declarations
:
: Guilherme Sacchi de Camargo Correia, Tanmayi Pai, Shenduo Li, Dana Connor, and Yujie Zhao declare no conflict of interest. Yanyan Lou has Sebastian Szmit has received research funding support from Merck, Tolero Pharmaceuticals, AstraZeneca, Blueprint Medicines, Sun Pharma, Mirati Therapeutics, Genmab, EMD Serono, Jacobio pharma, TOPALLIAN, and Daiichi Sankyo. Yanyan Lou participates in the advisory board for AstraZeneca Pharmaceuticals, Janssen Pharmaceutical, Lilly Oncology, Turning point therapeutics, Oncohost, and Mirati Therapeutics (Honorarium to Mayo Clinic). Rami Manochakian participates in the advisory board for AstraZeneca Pharmaceuticals, and Janssen Pharmaceutical.
: This article does not contain any studies with human or animal subjects performed by any of the authors.